logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

American residents' stock ownership ratio hits a new high! Experts sound the alarm: The economy will be more vulnerable to stock market shocks.

date
29/09/2025
Wise Finance APP learned that Americans are investing more money in the stock market than ever before. Although the rise in the stock market may have boosted investors' account balances, they are also more vulnerable to the impact of a stock market downturn than ever before.
Latest
2 m ago
Analysts: Brokerage stocks are one of the few sectors with significantly improved prospects and have not experienced a major increase.
2 m ago
Zhongrun Optics: Director Lu Gaofei intends to reduce his shareholding by no more than 0.7832%.
3 m ago
Lu Hua Securities was criticized and fined by the Hong Kong Securities and Futures Commission for mishandling client funds.
3 m ago
Dutch pharmaceutical company Merus soared more than 38% before the market opening, now trading at $95.2. Danish biotechnology company Genmab has agreed to acquire Merus for $97 per share in cash, with a transaction value of approximately $8 billion.
3 m ago
Hengrui Pharmaceuticals (600276.SH)'s subsidiary, HRS-2129 tablet, has received the approval notice for clinical drug trials.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.